Evidence map›Paper›PMID 30353868›Full record

ArticleThe Lancet. Neurology2018

Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Headache Collaborators

Erratum issued 8 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in The Lancet. Neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 8 registered trials, which are not on this map. Cited by 885 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
885citing papers in PubMed, 16 pooled it
106.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04520425 naterminatednot on this mapstarted 2022, after this paper: background citation

Osteopathic Manipulative Techniques for the Treatment of Chronic Migraine Headaches

TypeinterventionalSponsorMilton S. Hershey Medical CenterRan2022 to 2023Enrolled11ConditionsChronic Migraine, HeadacheArmsOsteopathic manipulative therapy
NCT05383365 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

The Effectiveness of Deep Neck Flexor Exercises in Comparison With Myofascial Release of Suboccipital Muscle on Pain and Forward Head Posture in People With Chronic Tension-type Headache and Forward Head Posture

TypeinterventionalSponsorIran University of Medical SciencesRan2024 to 2026Enrolled44ConditionsChronic Tension-Type HeadacheArmsSuboccipital Myofascial Release(MFR) with sham Deep Neck Flexor(DNF)exercise, Deep Neck Flexor(DNF)exercise with sham Suboccipital Myofascial Release(MFR)
NCT05416476 phase3unknown statusnot on this mapstarted 2023, after this paper: background citation

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study To Evaluate The Efficacy, Safety, And Tolerability Of Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine

TypeinterventionalSponsorSecond Affiliated Hospital, Zhejiang University, School of MedicineRan2023 to 2025Enrolled288ConditionsMigraine Without Aura, Migraine With AuraArmsAnisodine Hydrobromide, Anisodine Hydrobromide placebo
NCT05484349 phase3unknown statusnot on this mapstarted 2023, after this paper: background citation

Safety and Efficacy of Oral Tizanidine Hydrochloride in Preventing Migraine Attacks in Adult Migraine Patients: a Multicenter, Randomized, Double Blind, Placebo Controlled Clinical Study

TypeinterventionalSponsorSecond Affiliated Hospital, Zhejiang University, School of MedicineRan2023 to 2025Enrolled189ConditionsMigraine Without Aura, Migraine With AuraArmsTizanidine Hydrochloride, Tizanidine Hydrochloride Placebo
NCT05673330 nacompletednot on this mapstarted 2022, after this paper: background citation

Effects of Spinal Mobilization Versus Myofacial Release Techniques on Pain And Disability In Patients With Tension Type Headache

TypeinterventionalSponsorRiphah International UniversityRan2022 to 2023Enrolled34ConditionsTension Type HeadacheArmsSpinal Mobilizations, Myofascial Release Technique
NCT05891808 unknown statusnot on this mapstarted 2020, after this paper: background citation

Expression of miR-155 in Migraine: Association With Different Phenotypes and Disease Severity

TypeobservationalSponsorIRCCS National Neurological Institute "C. Mondino" FoundationRan2020 to 2024Enrolled90ConditionsMigraine, Headache, Pain, Chronic Migraine
NCT07040813 phase3recruitingnot on this mapstarted 2025, after this paper: background citation

A Randomized Placebo-controlled Double-blind Phase III Trial to Investigate the Reduction of Monthly Migraine Days (MMDs) Over 12 Weeks of Treatment With CGRP mAbs and Onabotulinumtoxin A Intramuscularly Compared With CGRP mAbs and Placebo in Chronic Migraine

TypeinterventionalSponsorOslo University HospitalRan2025 to 2029Enrolled450ConditionsMigraine, Chronic Migraine HeadacheArmsCGRP mAbs and onabotulinumtoxin A, CGRP mAbs and placebo
NCT07309874 narecruitingnot on this mapstarted 2026, after this paper: background citation

Effect of Ultrasound-Guided Dry Needling Targeting Rectus Capitus Posterior Major on Individuals With Headaches

TypeinterventionalSponsorTexas Tech University Health Sciences CenterRan2026 to 2026Enrolled50ConditionsHeadache Disorders, Primary, Headache, CervicogenicArmsDry needling
3 · Its place in the literature

Who cites it

885 citing papers in PubMed, 16 syntheses or guidelines pooled it, 1,911 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Efficacy and safety of Dingluo nasal drops for the acute treatment of migraine: a pilot randomized trial.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2026
    Trial
  18. Trial
  19. Trial
  20. A randomized crossover trial: The impact of ocular lubrication on migraine severity in persons with dry eye disease and migraine.Optometry and vision science : official publication of the American Academy of Optometry · 2025
    Trial

825 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

GBD 2016 Headache Collaborators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThrough the Global Burden of Diseases, Injuries, and Risk Factors (GBD) studies, headache has emerged as a major global public health concern. We aimed to use data from the GBD 2016 study to provide new estimates for prevalence and years of life lived with disability (YLDs) for migraine and tension-type headache and to present the methods and results in an accessible way for clinicians and researchers of headache disorders.

methodsData were derived from population-based cross-sectional surveys on migraine and tension-type headache. Prevalence for each sex and 5-year age group interval (ie, age 5 years to ≥95 years) at different time points from 1990 and 2016 in all countries and GBD regions were estimated using a Bayesian meta-regression model. Disease burden measured in YLDs was calculated from prevalence and average time spent with headache multiplied by disability weights (a measure of the relative severity of the disabling consequence of a disease). The burden stemming from medication overuse headache, which was included in earlier iterations of GBD as a separate cause, was subsumed as a sequela of either migraine or tension-type headache. Because no deaths were assigned to headaches as the underlying cause, YLDs equate to disability-adjusted life-years (DALYs). We also analysed results on the basis of the Socio-demographic Index (SDI), a compound measure of income per capita, education, and fertility.

findingsAlmost three billion individuals were estimated to have a migraine or tension-type headache in 2016: 1·89 billion (95% uncertainty interval [UI] 1·71-2·10) with tension-type headache and 1·04 billion (95% UI 1·00-1·09) with migraine. However, because migraine had a much higher disability weight than tension-type headache, migraine caused 45·1 million (95% UI 29·0-62·8) and tension-type headache only 7·2 million (95% UI 4·6-10·5) YLDs globally in 2016. The headaches were most burdensome in women between ages 15 and 49 years, with migraine causing 20·3 million (95% UI 12·9-28·5) and tension-type headache 2·9 million (95% UI 1·8-4·2) YLDs in 2016, which was 11·2% of all YLDs in this age group and sex. Age-standardised DALYs for each headache type showed a small increase as SDI increased.

interpretationAlthough current estimates are based on limited data, our study shows that headache disorders, and migraine in particular, are important causes of disability worldwide, and deserve greater attention in health policy debates and research resource allocation. Future iterations of this study, based on sources from additional countries and with less methodological heterogeneity, should help to provide stronger evidence of the need for action.

fundingBill & Melinda Gates Foundation.

Indexed as

Global HealthAdolescentAdultAgedAged, 80 and overAge DistributionBayes TheoremChildChild, PreschoolCommunity Health PlanningCross-Sectional StudiesFemaleGlobal Burden of DiseaseHumansMaleMiddle Aged

Identifiers

PMID30353868
PMCPMC6191530
OpenAlexW2895868360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

and 2 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.